Trademark: ATRECA 1803245
Word
ATRECA
ID
1803245
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
17 October 2016
Registration Date
17 October 2016
Renewal Date
17 October 2026
Owner(s)
Service
Pizzeys Patent and Trade Mark Attorneys Pty Ltd
Goods and Services:
Class 1:
Diagnostic preparations for research or scientific diagnosis use; biological tissue cultures for research and scientific diagnosis use; antibodies and antibody reagents for research and scientific diagnosis use; combinations of biological tissue cultures for research and scientific diagnosis use; combinations of antibodies and antibody reagents for research and scientific diagnosis use; buffers and chemical reagents for use in molecular biology research
Diagnostic preparations for research or scientific diagnosis use; biological tissue cultures for research and scientific diagnosis use; antibodies and antibody reagents for research and scientific diagnosis use; combinations of biological tissue cultures for research and scientific diagnosis use; combinations of antibodies and antibody reagents for research and scientific diagnosis use; buffers and chemical reagents for use in molecular biology research
Class 5:
Diagnostic preparations for medical use; diagnostic preparations for predicting the response of patients to therapeutics; biologics for medical use, namely, medical diagnosis; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious disease, cancer, autoimmune/inflammatory disease, cardiovascular disease, neurological disease, metabolic disease, respiratory disease and ophthalmic disease; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of animal disease; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; biologics, namely, vaccines for prophylaxis or treatment of human disease; biologics, namely, vaccines for prophylaxis or treatment of animal disease; combinations of biologics for medical use, namely, medical diagnosis; combinations of biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious disease, cancer, autoimmune/inflammatory disease, cardiovascular disease, neurological disease, metabolic disease, respiratory disease and ophthalmic disease; combinations of biologics for medical use, namely, biological preparations for the treatment or prophylaxis of animal disease; combinations of biologics, namely, vaccines for prophylaxis or treatment of human disease; combinations of biologics, namely, vaccines for prophylaxis or treatment of animal disease; combinations of biologics, namely, biological tissue cultures, antibodies, and vaccines, for medical diagnosis; diagnostic preparations for clinical, medical laboratory diagnosis use; biological tissue cultures for clinical, medical laboratory diagnosis use; antibodies and antibody reagents for clinical, medical laboratory use; combinations of biological tissue cultures for clinical, medical laboratory diagnosis use; combinations of antibodies and antibody reagents for clinical, medical laboratory diagnosis use
Diagnostic preparations for medical use; diagnostic preparations for predicting the response of patients to therapeutics; biologics for medical use, namely, medical diagnosis; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious disease, cancer, autoimmune/inflammatory disease, cardiovascular disease, neurological disease, metabolic disease, respiratory disease and ophthalmic disease; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of animal disease; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; biologics, namely, vaccines for prophylaxis or treatment of human disease; biologics, namely, vaccines for prophylaxis or treatment of animal disease; combinations of biologics for medical use, namely, medical diagnosis; combinations of biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious disease, cancer, autoimmune/inflammatory disease, cardiovascular disease, neurological disease, metabolic disease, respiratory disease and ophthalmic disease; combinations of biologics for medical use, namely, biological preparations for the treatment or prophylaxis of animal disease; combinations of biologics, namely, vaccines for prophylaxis or treatment of human disease; combinations of biologics, namely, vaccines for prophylaxis or treatment of animal disease; combinations of biologics, namely, biological tissue cultures, antibodies, and vaccines, for medical diagnosis; diagnostic preparations for clinical, medical laboratory diagnosis use; biological tissue cultures for clinical, medical laboratory diagnosis use; antibodies and antibody reagents for clinical, medical laboratory use; combinations of biological tissue cultures for clinical, medical laboratory diagnosis use; combinations of antibodies and antibody reagents for clinical, medical laboratory diagnosis use
Class 42:
Research, design and development of diagnostics for predicting or monitoring the response of patients to therapeutics; research, design and development of biologics for predicting or monitoring the response of patients to therapeutics; research, design and development of combinations of such diagnostics and biologics; research, design and development of diagnostics for diseases in humans and animals, namely, infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases; research, design and development of biologics for the treatment or prophylaxis of human and animal diseases, namely, infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases; research, design and development of combinations of diagnostics and biologics for the treatment or prophylaxis of human and animal diseases, namely, infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases
Research, design and development of diagnostics for predicting or monitoring the response of patients to therapeutics; research, design and development of biologics for predicting or monitoring the response of patients to therapeutics; research, design and development of combinations of such diagnostics and biologics; research, design and development of diagnostics for diseases in humans and animals, namely, infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases; research, design and development of biologics for the treatment or prophylaxis of human and animal diseases, namely, infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases; research, design and development of combinations of diagnostics and biologics for the treatment or prophylaxis of human and animal diseases, namely, infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases and ophthalmic diseases